Enhancing Cancer Care
For Safer and More Effective Treatment
A Dye, a Linker, and a Drug Payload
A cleavable linker connects a tumor-targeting dye to a drug payload. The drug is non-toxic while it is attached to the linker.
​
01
The Drug Payload is Delivered to the Tumor Site
The tumor-targeting dye and the drug payload travel throughout the body, finding only the cancer cells wherever they are.
02
The Drug Payload is Released Only Within the Tumor
Once inside the cancer cell, the unique chemistry found in the cancer cell dissolves the linker, releasing the drug and turning it on.
Now it can act to kill cancer
03
This Is How Our Dye Drug Conjugates Work.
Pioneering Hope in Cancer Treatment.
Lyle Small, founder and CEO of Lahjavida, Inc., brings over 30 years of expertise in dyes, coatings, and ink technology, having pioneered advancements at Chromatic Technologies, Inc. (CTI) with over 35 unique technologies. At Lahjavida, he is transforming cancer treatment by combining tumor-targeting dyes with drug payloads, showing promise in selectively eliminating cancer cells and inspiring hope for more effective therapies.
The Approach From Lahjavida.
Our revolutionary dye targets over 30 cancer types, delivering drug payloads directly to tumors through a specialized linker that activates only at the cancer site.
